Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Novartis Key MS Product Gilenya Approved in China (2019-07-19)
> Chinese National Medical Products Administration (NMPA) approved Gilenya® for relapsing forms of multiple sclerosis (RMS) for adults and children 10 years and older. > Multiple sclerosis (MS) is categorized as rare disease in China with an estimated 30,00...
Medicxi Closes New €400m Fund (Medicxi III) (2019-07-19)
> €400m Medicxi III fund, closed in just six weeks, and brings the total funds raised by Medicxi in the last three years to over $1b > Medicxi III will invest across the full healthcare continuum, from discovery to late stage clinical assets, empowering ambitiou...
Silence Therapeutics & Mallinckrodt: RNAi Therapeutics (2019-07-18)
-- Collaboration advances Silence’s proprietary platform in the growing field of RNAi technology -- Agreement provides Mallinckrodt with an exclusive worldwide license for one preclinical asset that targets a specific protein in the complement pathway, C3 (S...
Mallinckrodt: $5m Equity Investment in Silence Therapeutics (2019-07-18)
Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases - Mallinckrodt Chief Scientific Officer Steven Romano, M.D. joins Silence Board as nonexe...
Merck and Broad Institute Announce CRISPR License Framework (2019-07-18)
New framework simplifies and accelerates access to CRISPR intellectual property for research Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive...
Immunic, Inc. Appoints Sanjay S. Patel as CFO (2019-07-16)
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment of Sanjay S. Patel, CFA, as C...
AM-Pharma Raises €116m Round Led by LSP & Andera Partners (2019-07-16)
Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthcare Proceeds to be used for the 1,400-patient international piv...
Sosei Heptares & Genentech: GPRC-targeting Partnership (2019-07-16)
Collaboration aims to discover and develop novel medicines that modulate G protein-coupled receptor (GPCR) targets across a range of diseases Sosei Group Corporation (“the Company”; TSE: 4565) announces that it has entered into a multi-target research colla...
Recursion Pharmaceuticals Secures $121m Series C Round (2019-07-15)
Led by Baillie Gifford’s Scottish Mortgage Investment Trust PLC, the new round will support the advancement of Recursion’s machine learning-enabled platform and first two clinical-stage programs Recursion, a next-gen biopharma company combining automated, expe...
Boehringer Acquires Amal Therapeutics for up to €325m (2019-07-15)
> Acquisition adds key platform supporting Boehringer Ingelheim’s focus on patients with difficult-to-treat gastrointestinal and lung cancers > AMAL’s first-in-class proprietary KISIMA® platform leverages peptide/protein-based vaccination technology > AMAL ...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]